Numerous new antifolate drugs have been developed in an attempt to overcome the potential mechanisms of tumor cell resistance to methotrexate, which can include decreased drug transport into cells; decreased
Carmen J. Allegra, MD
Advertisement
Articles by Carmen J. Allegra, MD
Advertisement
Latest Updated Articles
- New Antifolates in Clinical Development
Published: July 1st 1995 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Epcoritamab Combo in R/R Follicular Lymphoma
2
Giredestrant Exhibits DFS Improvement in Early-Stage Breast Cancer
3
NALIRIFOX Shows Survival Benefit Vs Gemcitabine/Nab-Paclitaxel in Metastatic PDAC
4
How Does NALIRIFOX Fit Into the Metastatic PDAC Treatment Paradigm?
5
